Lebwohl David

EDGAR CIK 0001810882

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
EVP, Chief Medical Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($172,135)
-5,843 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/03/2024
01/05/2024
Sell
-5,843 @ $29.46
 ($172,135) 54,372 (-9.70%) Direct